Screener
XBI vs KCE
State Street SPDR S&P Biotech ETF vs State Street SPDR S&P Capital Markets ETF
Key differences
- XBI is significantly larger than KCE — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, KCE has delivered higher annualized returns.
Side-by-side comparison
| XBI | KCE | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $8.3B | $456M |
| Since | 2006 | 2005 |
| Dividend yield | 0.34% | 1.70% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +66.6% | +15.1% |
| CAGR 3Y | +15.6% | +26.5% |
| CAGR 5Y | +0.9% | +12.9% |
| Sharpe 3Y | 0.54 | 1.05 |
| Volatility 1Y | 25.14% | 19.67% |
| Max drawdown | -63.89% | -40.78% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XBI and KCE
Explore further